Alaethes Wealth LLC Eli Lilly & CO Transaction History

Alaethes Wealth LLC

$236 Million
Q2 2024

A detailed history of Alaethes Wealth LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Alaethes Wealth LLC holds 488 shares of LLY stock, worth $432,338. This represents 0.19% of its overall portfolio holdings.

Number of Shares

488

Previous 488 -0.0%

Holding current value

$432,338

Previous $379,000 16.36%

% of portfolio

0.19%

Previous 0.17%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $56,259 - $75,266	-95 Reduced 16.3%	488 $379,000
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $169,636 - $199,978	-323 Reduced 35.65%	583 $339,000
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $2,608 - $3,595	6 Added 0.67%	906 $486,000
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $24,551 - $32,828	70 Added 8.43%	900 $422,000
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $27,646 - $32,468	89 Added 12.01%	830 $285,000
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $1.46 Million - $1.71 Million	-4,553 Reduced 86.0%	741 $271,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $142,606 - $162,515	481 Added 9.99%	5,294 $1.71 Million
Q2 2022 Aug 16, 2022	SELL	$278.73 - $327.27 $70,797 - $83,126	-254 Reduced 5.01%	4,813 $1.56 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $26,285 - $32,665	112 Added 2.26%	5,067 $1.45 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $113,099 - $140,357	503 Added 11.3%	4,955 $1.37 Million
Q3 2021 Nov 16, 2021	SELL	$221.6 - $272.71 $32,575 - $40,088	-147 Reduced 3.2%	4,452 $1.03 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $27,263 - $35,264	151 Added 3.39%	4,599 $1.06 Million
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $730,895 - $946,178	4,448 New	4,448 $831,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $842B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaethes Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alaethes Wealth LLC with notifications on news.

Account

Alaethes Wealth LLC Eli Lilly & CO Transaction History